Compare BVS & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | VTEX |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.2M | 673.4M |
| IPO Year | 2016 | 2019 |
| Metric | BVS | VTEX |
|---|---|---|
| Price | $11.85 | $3.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $14.00 | $5.97 |
| AVG Volume (30 Days) | 706.8K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | $12.78 |
| Revenue Next Year | $7.06 | $9.63 |
| P/E Ratio | $287.00 | ★ $43.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $2.84 |
| 52 Week High | $12.53 | $6.30 |
| Indicator | BVS | VTEX |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 48.25 |
| Support Level | $8.04 | $3.71 |
| Resistance Level | $12.53 | $4.19 |
| Average True Range (ATR) | 0.54 | 0.17 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 41.30 | 22.34 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.